Galapagos NV

( )
GLPG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 1.59%154.960.0%$1509.75m
NVAXNovavax, Inc. 2.55%79.1878.2%$568.86m
AMGNAmgen, Inc. -1.11%222.541.4%$546.33m
GILDGilead Sciences, Inc. -2.18%67.341.0%$534.08m
BIIBBiogen, Inc. -1.22%219.601.8%$496.23m
BNTXBioNTech SE 2.69%160.700.0%$493.59m
REGNRegeneron Pharmaceuticals, Inc. 0.34%605.252.7%$434.03m
ILMNIllumina, Inc. -3.77%331.783.3%$370.86m
VRTXVertex Pharmaceuticals, Inc. -0.23%226.581.9%$358.72m
SNSSSunesis Pharmaceuticals, Inc. -4.71%2.630.7%$183.85m
EXASEXACT Sciences Corp. -0.42%68.8917.9%$173.71m
INCYIncyte Corp. -0.85%73.522.4%$141.06m
ARNAArena Pharmaceuticals, Inc. -0.29%89.6313.7%$135.69m
BMRNBioMarin Pharmaceutical, Inc. -1.37%83.704.2%$108.53m
CRSPCRISPR Therapeutics AG -1.12%61.840.6%$107.20m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.